United States Drug Enforcement Administration

This document is an internal Drug Enforcement Administration quality system document for latent print examination.  The effective period of the document is May 4, 2020 to August 18, 2022 and it is provided for informational purposes only.  Any sensitive, privileged or otherwise protected information has been redacted, to include the redaction of some documents in their entirety. All redactions are clearly present in this document. Names of commercial manufacturers are provided for identification only and inclusion does not imply endorsement by the Drug Enforcement Administration.